Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion type Assertion NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_head.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion description "[Our results suggest that TRIM16 is a potential pharmacologic target for the treatment of NSCLC and promotion TRIM16 expression might represent a novel strategy to NSCLC metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_provenance.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion evidence source_evidence_literature NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_provenance.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion SIO_000772 25843803 NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_provenance.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion wasDerivedFrom befree-2016 NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_provenance.
- NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_assertion wasGeneratedBy ECO_0000203 NP1276022.RAdvNdQ_NM4hDdPqb5YF1XFOYu1pyDEIp3LtggNDVJSo4130_provenance.